KAIST 생명과학과동창회
  • News & Events
  • News

News

Growing up curious in the countryside leads to tools for manipulating endogenous proteins.

 

 

허원도 교수님 사진.jpg



Won Do Heo

“Good ideas come to me when I am very comfortable, when I am very happy,” says Won Do Heo, who is on the biology faculty at Korea Advanced Institute of Science and Technology (KAIST), and is a neuroscience fellow at the Institute for Basic Science, both in Daejon, Republic of Korea. An idea might come to him in a lab conversation, at a seminar or conference, when he is jogging, on one of his daily walks on a hill, or in the sauna at home.

 

It was a Korean national holiday and Heo was alone in the lab, thinking. He had spent a decade developing and using optogenetic tools. Suddenly, he realized how he might finally turn intrabodies, which are antibodies used to study intracellular proteins, into inducible tools.

 

Heo and his lab converted the idea into two classes of tools to target and manipulate proteins inside cells: optobodies, which can be activated by light; and chemobodies, which can be activated by small molecules. These tools leverage nanobodies, based on camelid antibodies, that are prized in cell biology for being soluble and small they’re around half the size of a green fluorescent protein molecule.

 

During that holiday musing, Heo had figured out at which cysteine residues he could split the nanobody to generate two inactive parts that do not bind a targeted protein. He checked the nanobody structure, and experiments got underway. The split structure lets an experimenter use light to, for example, activate or inhibit a protein at the cell membrane, at an organelle or in the cell nucleus. When the nanobody halves are separate, it’s like having only one chopstick for a meal, he says. Work only gets done when the other half enters the scene.

 

The tools offer high-resolution temporal and spatial information about endogenous proteins, says Heo. With optobodies, light can help with manipulating a targeted protein and thus shape cell function. The team’s chemobody would be good for an in vivo experiment, he says. Such studies, for example in neurobiology, are on his to-do list.

 

The lab used blue light to activate the optobody, but Heo believes he can get the tools to work with infrared light, too. Although there are many types of nanobodies, he believes the tools will work across this antibody class and for many types of questions. The chosen split site is in the antibody’s highly conserved domain.

 

In his lab, says Heo, tool development involves intense testing, which takes a collaborative lab culture. Lab members not involved in a project are a tool’s first users. This arrangement is not easy given his students’ eagerness to publish quickly. But Heo seeks generalizable, broadly applicable tools. “I don’t make very special, very tricky things,” he says, which might only work in a few labs.

 

In his lab, Heo encourages his students to explore projects that intrigue them and that will make them happy during their years in his lab. “If they are not happy with something, I won’t be happy, too.”

 

Heo grew up on a farm in the country. “I didn’t really have the plan to be a professorresearcher at the time,” he says. He played with his dog, rabbit and cows, and was curious about how they interacted and cared for their young. He learned about rice and barley farming. “It’s not textbook, it’s just nature,” he says. In high school, he began breeding birds: peacocks, turkeys, pheasants, parrots and canaries.

 

Even college was not in his plans, but curiosity led him to Gyeongsang National University. “I realized that I had to step up to another level,” he says. Heo studied plant biology and switched to biochemistry in graduate school.

 

For his postdoctoral fellowship, curiosity was again a driver. He wanted to work in mammalian systems, and joined the Duke University lab of Tobias Meyer. Heo followed Meyer to Stanford University where, after a few years, he was promoted to staff researcher. After nine years in California, Heo joined KAIST and chose to focus on optogenetics.

 

Heo feels he can now combine his experience across fields: plant biology, cell biology, cell signaling and neurobiology. As Heo completed his PhD, he remembers realizing that many plant proteins are not present in mammals, which might make them useful tools, he says. This idea has emerged as a cornerstone of optogenetics.

 

Optogenetics has taken cell biology labs beyond observation, which might miss half of the actual cellular events. Cells “are talking to each other, communicating to each other,” he says. The ability to activate or deactivate proteins with light gives labs a way to explore cell biology more deeply and can help them, for example, determine proteins crucial to the cell cycle.

 

“If they are not happy with something, I won’t be happy.”

 

“I admire Won Do’s work for its creativity; he has applied optical control by the cryptochromeCIB1 interaction in very imaginative ways,” says Heo’s friend and colleague, Stanford University researcher Michael Lin. Heo and his students don’t shy away from the hard work necessary to realize their ideas, says Lin. “Developing truly new methods is high-risk and time-consuming, but Won Do has shown that the high rewards make it worth it.”



출처: Nature Methods > This month >

       https://www.nature.com/articles/s41592-019-0626-1


List of Articles
번호 제목 글쓴이 날짜 조회 수
372 [김찬혁 교수님] 6월 ‘이달의 과학기술인상’ 수상 생명과학과 2023.06.08 278
371 [김찬혁 교수님] 말기 고형암 표적 2세대 면역치료제 개발​ 생명과학과 2023.04.20 400
370 [김찬혁 교수님] 서울대병원, '꿈의 항암제' CAR-T 임상1상 본격 돌입 생명과학과 2022.02.04 617
369 [김찬혁 교수님] 카이스트, 면역관문 신호 극복하는 차세대 CAR-T 세포 치료제 개발 생명과학과 2021.11.24 636
368 [김찬혁, 정원석 교수님] 심각한 염증 부작용 없앤 새로운 알츠하이머병 치료제 개발​ 생명과학과 2022.08.22 633
367 [김학성 교수님, 김홍식 박사님] 암세포에만 약물 전달 가능한 클라트린 조립체 개발​ 생명과학과 2023.03.15 382
366 [김학성 교수님] 알츠하이머 조기 진단하는 센서단백질 디자인하다​ 생명과학과 2023.12.08 225
365 [김학성 교수님] 카이스트, 거대 단백질 구조체를 레고 블록 쌓듯 조립하는 기술 개발 생명과학과 2021.11.24 707
364 [김학성 명예교수님] 2023 효소공학상(Enzyme Engineering Award) 수상​ 생명과학과 2023.08.24 238
363 [대덕넷] 노화억제 비밀 밝혀낸 김태국 교수...연구성과 집대성 '풀베팅' 과사무실 2006.06.12 14175
362 [대덕넷] 생명과학과 정종경교수... 과기부 2분기 우수과학자 10인 선정 과사무실 2007.09.04 13655
361 [대덕넷] 임대식 교수 이달의 과기인상 수상 과사무실 2004.08.30 13003
360 [대덕넷] 임대식 교수"癌 억제하는 유전자 기능 밝혀졌다" 과사무실 2004.02.06 13533
359 [대덕넷] 제넥셀, 日 신약개발업체서 외자유치 과사무실 2005.03.31 10923
358 [동아일보] 김은준 교수 젊은 과학자상 수상 과사무실 2004.12.27 11933
357 [동아일보] 노화억제 신약후보물질 개발…김태국 교수팀 과사무실 2006.06.12 11315
356 [동아일보] 뇌 신호전달 작동물질 첫 발견-김은준교수팀 과사무실 2006.04.20 12023
355 [동아일보] 위암 당뇨 ‘맞춤 치료’ 길 열린다…SNP 지도 첫 완성 과사무실 2006.12.14 13357
354 [동아일보] 한국 과학에 세계가 또 놀라다 -정종경교수팀 과사무실 2006.05.04 14542
353 [동아일보] 혈관형성 촉진제 이용 만성 신장질환 고쳐요-고규영교수 과사무실 2006.08.03 11576
Board Pagination Prev 1 2 3 4 5 6 7 8 9 10 ... 22 Next
/ 22